ArticleFrontiers in oncology2026
Risk factors associated with cerebellar mutism syndrome and late postoperative hydrocephalus following pediatric posterior fossa medulloblastoma surgery.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the risk factors for postoperative complications in pediatric patients with posterior cranial fossa medulloblastoma(MB). Methods: A retrospective analysis was performed based on the clinical data of 53 pediatric patients with posterior fossa medulloblastoma treated in Tangdu Hospital, from Dec, 2016 to May, 2024. Various data points, including age, gender, tumor maximum diameter, surgical approach, and complications, were collected and statistically evaluated for an association with cerebellar mutism syndrom(CMS) and late postoperation hydrocephalus (LPH). Results: The median age of 53 patients with MB was 6.75 years (interquartile range, 5.4-9.2years). The surgical approach used was the classic telovelar approach for 32 patients, the transvermian approach for 21 patients. Of the 53 children, 10 cases had developed cerebellar mutism syndrom and were included in the CMS group, with 43 patients in the non-CMS group. 9 cases had developed late postoperative hydrocephalus, Four patients were asymptomatic with normal cerebrospinal fluid (CSF) pressure on lumbar puncture and were managed conservatively with close clinical monitoring. the remaining five patients exhibited symptoms of elevated intracranial pressure-including headache and nausea-and demonstrated elevated CSF pressure on lumbar puncture; all underwent ventriculoperitoneal shunt placement. Statistical analysis revealed that tumor maximum diameter (OR 16.97, Conclusion: Our CMS rate is comparable to those reported in the literature. Despite the inherent limitations of the retrospective study design, our findings indicate that CMS was not only associated with the transvermian approach but also significantly linked to tumor's maximum diameter. Furthermore, CSF-related complications were identified as independent risk factors for LPH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.